预测静脉动脉风暴中的存活率:CHAMPS风险评分和对切除时间的影响
Darshak Patel1, Ufuk Vardar2, William Mai2
1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
JACC. Clinical electrophysiology
|January 15, 2026
概括
静脉动脉冲动 (VT) 风暴带来了高死亡风险. CHAMPS评分可以识别高风险患者,早期导管切除可显著改善所有风险类别的生存率.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 临界护理医学 临界护理医学
背景情况:
- 静脉动脉风 (VT) 风暴是一种危急的病情,具有显著的住院死亡风险.
- 有限的数据存在于识别高风险患者和VT风暴中导管切除的最佳时间.
- 这项研究通过分析静脉瘤风暴患者的预测因子和切除时间来解决这些差距.
研究的目的:
- 为了确定患有静脉瘤风暴的患者住院死亡率的预测因素.
- 为分层死亡风险制定临床风险评分 (CHAMPS).
- 评估导管切除时间对不同风险层的存活率的影响.
主要方法:
- 来自六个三级保健中心的1675名静脉风患者 (2015-2024) 的回顾性分析.
- 多变量逻辑回归确定了死亡率预测因素,构成了CHAMPS得分的基础.
- 通过风险层和废除时间对死亡率进行比较.
主要成果:
- 住院死亡率为22% (363/1,675名患者).
- 关键的死亡预测因素包括脑血管事故,缺氧,非静脉治疗入院诊断,营养不良,血管压缩剂使用和败血症.
- 在CHAMPS得分中,患者被分为低 (6.6%),中度 (26.7%) 和高 (60.7%) 的死亡风险组.
- 早期静脉管切除 (7天内) 能够防止住院死亡率 (OR:0.01),独立于CHAMPS得分.
结论:
- CHAMPS评分有效地识别了在静脉风暴期间存在高死亡风险的患者.
- 早期导管切除证明了静脉风患者的显著生存益处,无论他们的风险得分如何.
- 这些发现支持风险分层和及时干预,以改善VT风暴的结果.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
675
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
675
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
471
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
471
Cardiopulmonary Resuscitation III: AED Use
547
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
547
Disturbances in Heart Rhythm
2.6K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.6K
Dysrhythmias II: Classification of Tachyarrhythmias
500
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
500
Dysrhythmias VI: Management of Dysrhythmias
433
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
433


